TB-500
Healing & Recovery · 10 mg fill · Research Peptide
A synthetic thymosin beta-4 fragment studied across actin-binding, cell-migration and matrix-remodeling models.
Overview
TB-500 is a synthetic peptide corresponding to the actin-binding domain of thymosin beta-4 (Tβ4), an endogenous protein involved in cytoskeletal regulation. It is referenced across preclinical work on cell migration, angiogenesis and extracellular-matrix remodeling; the published record is animal and in-vitro only, with no controlled human trials. Supplied as a high-purity lyophilized preparation for in-vitro research use.
Specifications
- Sequence
- Thymosin beta-4 fragment · actin-binding LKKTETQ domain
- Form
- Lyophilized powder
- Vial Size
- 10 mg
- Purity
- >99% (HPLC)
- Reconstitution
- Bacteriostatic water
- Storage
- −20°C · protect from light
- Documentation
- Batch-specific COA
Research applications
- Actin-binding and cytoskeletal-regulation assays
- Cell-migration and matrix-remodeling models
- Angiogenesis research
- Inflammatory-signaling pathway studies
For research use only. This product is intended for laboratory and educational research purposes only. It has not been evaluated by the FDA and is not for human or veterinary consumption, diagnosis, treatment, or cure of any condition.
View in catalogOrdering, vial options and the cart live in the catalog view.